Biodistribution, molecular imaging and efficacy evaluation of a novel GPC3-targeted radiopharmaceutical therapy for hepatocellular carcinomaCANCER RESEARCHIF16.62024-03-220PRE
GPC3-targeted radiopharmaceutical therapy for neuroendocrine prostate cancerCANCER RESEARCHIF16.62024-03-220PRE
Peptide Binder to Glypican-3 as a Theranostic Agent for Hepatocellular CarcinomaJOURNAL OF NUCLEAR MEDICINEIF9.12024-02-297PRE
Anti-tumor activity of RYZ101 (Ac-225 DOTATATE) in somatostatin receptor-expressing preclinical models of small-cell lung cancerCANCER RESEARCHIF16.62023-04-041PRE
IFN-gamma AU-rich element removal promotes chronic IFN-gamma expression and autoimmunity in miceJOURNAL OF AUTOIMMUNITYIF72014-09-0189OA
Interferons: Success in anti-viral immunotherapyCYTOKINE & GROWTH FACTOR REVIEWSIF11.82014-08-01227OAAI
Loss of IFN-gamma 3′untranslated region AU-rich element affects B220+cell populations in novel murine lupus modelCYTOKINEIF3.72013-09-010PREAI
IFN-gamma causes aplastic anemia by altering HSC composition and interrupting lineage differentiationCYTOKINEIF3.72013-09-010PREAI
IKKα inactivation predisposes to spontaneous lung squamous cell carcinomasCANCER RESEARCHIF16.62012-04-010PRE
Lower Levels of Gamma Interferon Expressed by a Pseudotyped Single-Cycle Simian Immunodeficiency Virus Enhance Immunogenicity in RatsJOURNAL OF VIROLOGYIF3.82009-02-153OAAI
Incorporation of CD40 Ligand into the Envelope of Pseudotyped Single-Cycle Simian Immunodeficiency Viruses Enhances ImmunogenicityJOURNAL OF VIROLOGYIF3.82009-02-0112OAAI
Pseudotyped single-cycle simian immunodeficiency viruses expressing gamma interferon augment T-cell priming responses in vitroJOURNAL OF VIROLOGYIF3.82007-03-016OAAI